(028) 7309 6039
Home
About us
About us
Company History and Development
Production Bases
Company Organization Chart
Distribution System
Annual Revenue
Products
Cough Suppressants Expectorants and Mucolytics
Antibiotics
Oral Solid Dosage Form
Injection
Analgesics, Anti-Inflammatory and Antipyretic...
Antihistamines and Combinations
Antiprotozoal Agents
Vaginal Preparations
Antimalarials
Antituberculosis Agents
Infusions
Irrigation Solutions
Creams & Ointments
Gastrointestinal Agents
Anthelmintics
Cardiovascular Drugs
Metabolism drugs
Raw Material
Cosmetics
Shareholders
Notice
Dividend
Shareholders
Shareholders Meeting
Share transaction of internal and major shareholders
MKP shares information
Annual Revenue
Financial Revenue
Corporate governance reports
Mekophar information
Leaders
Company rules
Members & relationship
Customer
Recruitment
Contact us
Company History and Development
Founded in 1975, bearing the name Central Pharmaceutical Enterprise No 24, which is a member of Vietnam Pharmaceutical Corporation.
In 1985 it merged with Central Pharmaceutical Enterprise No 22, and renamed as Central Pharmaceutical Factory No 24 - MEKOPHAR.
In 1993, it took part in a joint-venture with South Korean company, Woopyung, to form a joint-venture company Woopyung - Mekophar, which is the first and one only in Vietnam producer of semi-synthetic betalactam antibiotics such as: Amoxicilin, Ampicilin.
In 2000, Central Pharmaceutical Enterprise No 24 bought back the whole part of its business partner in the joint-venture company Woopyung-Mekophar which became the Betalactam Antibiotic Factory of the Central Pharmaceutical Enterprise No 24.
In 2001,it had been renamed officially as
Mekophar Chemical Pharmaceutical Joint Stock Company
. (as per Decision No 1589/QĐ-TTg, on 12/19/2001 by the Prime Minister of the Government in relation of the equitization of the Central Pharmaceutical Enterprise No 24 – a member unit of Vietnam Pharmaceutical Corporation). Officially changes its mode of business operation from state-owned enterprise into share-holding company with the legal capital of VNĐ 36 billions.
In 2003, the Company invested the founding shares in An Sinh General Hospital and the Hospital went into business on 05/07/2006.
In 2006, the Company debuted its IPO, with stock code
MKP,
its legal capital is increased to VNĐ 84 billions.
In 2008, the stem cell bank has been established as MekoStem (as per Decision No 4001/UBND-VX issued by People Committe of Ho Chi Minh city on 06/25/2008) and got Business License No 3144/QĐ-BYT by the Ministry of Health of Vietnam on 08/03/2011.
The chartered capital is increased to VND 92.1 billions.
In 2010, the Company is listing and exchanging its stock on HOSE floor (Ho Chi Minh Stock Exchange).
In 2011, the chartered capital is increased to VND 101,159,320,000
In 2014, the chartered capital is increased to VND 131,234,130,000
In 2015, the chartered capital is increased to VND 151,234,130,000
In 2016, the chartered capital is increased to VND 194,208,130,000
Notice 39: Change of company model and type of financial statements
